TABLE 1.
Concept Map of Vignettes
Vignette | Treatment | Acute | Bother | Control | Direction | Wheeze |
---|---|---|---|---|---|---|
No. | Care | |||||
1a | Low intensity | No | No | Symptoms once per 2 wk | Unchanged | No |
2 | Low intensity | No | No | Symptoms once per 2 wk | Unchanged | Yes |
3 | Low intensity | Yes | No | Symptoms once per 2 wk | Unchanged | No |
4 | Low intensity | No | Yes | Symptoms once per 2 wk | Unchanged | No |
5 | Low intensity | No | No | Symptoms 4–5 times per wk | Unchanged | No |
6 | Low intensity | No | No | Symptoms once per 2 wk | Worse | No |
7b | High intensity | No | No | Symptoms once per 2 wk | Unchanged | No |
8 | High intensity | Yes | No | Symptoms once per 2 wk | Unchanged | No |
9 | High intensity | No | Yes | Symptoms once per 2 wk | Unchanged | No |
10 | High intensity | No | No | Symptoms once per 2 wk | Worse | No |
11 | High intensity | Yes | Yes | Symptoms once per 2 wk | Worse | No |
Low-intensity treatment indicates low ICS (fluticasone [44 µg per puff] 2 puffs twice per day) and albuterol as needed; high-intensity treatment, high ICS (fluticasone [220 µg per puff] 2 puffs twice per day), LABA, LTM, and albuterol as needed. Analyses compared vignettes 2, 3, 4, 5, and 6 with vignette 1 (stepping-up baseline), and vignettes 8, 9, 10, and 11 were compared with vignette 7 (stepping-down baseline).
Stepping-up baseline.
Stepping-down baseline.